Literature DB >> 2611932

Corticosterone secretion-inducing activity of saikosaponin metabolites formed in the alimentary tract.

M Nose, S Amagaya, Y Ogihara.   

Abstract

The corticosterone secretion-inducing activities of saikosaponin a, saikosaponin c and saikosaponin d, isolated from the root of Bupleurum falcatum L., and 27 metabolites formed in the murine alimentary tract were studied in mice. Serum corticosterone was determined by high-performance liquid chromatography (HPLC). Intraperitoneal administration of saikosaponin a and its intestinal metabolite, prosaikogenin F, showed corticosterone secretion-inducing activity at a dose of 0.1 mmol/kg, and maximally increased it at a dose of 0.4 mmol/kg. On the other hand, the genuine sapogenin, saikogenin F, was inactive. Saikosaponin b1 and saikosaponin g, gastric metabolites of saikosaponin a, and their intestinal metabolites, prosaikogenin A, prosaikogenin H, saikogenin A and saikogenin H, were also inactive. Serum corticosterone was increased by the administration of saikosaponin d and its intestinal metabolite, prosaikogenin G, at a dose of 0.04 mmol/kg, and it reached the maximal level at the dose of 0.1 mmol/kg. Saikogenin G also showed a slight activity. A gastric metabolite of saikosaponin d, saikosaponin b2, and its intestinal metabolites, prosaikogenin D and saikogenin D, were inactive. In the experiments on saikosaponin c and its metabolites, saikosaponin c was inactive but its intestinal metabolites, especially prosaikogenin E-2, showed activity almost equal to that of saikosaponin a. Saikosaponin h and saikosaponin i, gastric metabolites of saikosaponin c, were also inactive, but their prosaikogenins showed slight activities. When these compounds were orally administered, their corticosterone secretion-inducing activities were similar to those obtained in the intraperitoneal experiment. These results suggest that a proper polar balance between the sugar moiety and the aglycone is important for the corticosterone secretion-inducing activity of saikosaponins and their metabolites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2611932     DOI: 10.1248/cpb.37.2736

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  Bu-zhong-yi-qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model.

Authors:  Mingzi Ouyang; Yanyan Liu; Wei Tan; Ya Xiao; Keqiang Yu; Xiaomin Sun; Ying Huang; JingRu Cheng; Ren Luo; Xiaoshan Zhao
Journal:  BMC Complement Altern Med       Date:  2014-12-15       Impact factor: 3.659

2.  Ultrasensitive Time-Resolved Fluoroimmunoassay for Saikosaponin a in Chaihu (Bupleuri Radix).

Authors:  Zhi Chao; Qian Cui; Enwei Tian; Weiping Zeng; Xuan Cai; Xiaolei Li; Hiroyuki Tanaka; Yukihiro Shoyama; Yingsong Wu
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

Review 3.  Separation and isolation methods for analysis of the active principles of Sho-saiko-to (SST) oriental medicine.

Authors:  Nobuhiro Ohtake; Yoichiro Nakai; Masahiro Yamamoto; Iwao Sakakibara; Shuichi Takeda; Sakae Amagaya; Masaki Aburada
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-12-05       Impact factor: 3.205

4.  Antioxidant and Protective Effects of Bupleurum falcatum on the L-Thyroxine-Induced Hyperthyroidism in Rats.

Authors:  Seong-Mo Kim; Sang-Chan Kim; In-Kwon Chung; Woo-Hyun Cheon; Sae-Kwang Ku
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-25       Impact factor: 2.629

5.  Quality control of tuirejieduling granules using high-performance liquid chromatography fingerprint method and simultaneous determination of four main active ingredients.

Authors:  Aixia Yang; Xiaoxian Wang; Chaomei Xiong; Jing Chen; Jinlan Ruan
Journal:  Pharmacogn Mag       Date:  2013-04       Impact factor: 1.085

6.  Mouse single oral dose toxicity test of bupleuri radix aqueous extracts.

Authors:  Kyung-Hu Kim; Cheol-Ou Gam; Seong-Hun Choi; Sae-Kwang Ku
Journal:  Toxicol Res       Date:  2012-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.